Anna founded ACBio to make life science innovations technically understandable, impactful, and valued by customers, partners, investors, healthcare professionals, and the public. Throughout her research career (PhD at King's College London and postdoc at University of Oxford), Anna investigated crucial molecular and cellular mechanisms of cell division, viral particle release, and endocytosis. She combined her research with science communication, writing for different outlets and magazines. Between 2019 and 2024, Anna worked in UK biotech (Oxford Nanoimaging, ONI), developing key skills in marketing, product management, business development, and content strategy, and deep knowledge of microscopy and nanobiotechnology (EVs and LNPs). In September 2024, Anna founded ACBio in Switzerland to help biotech, CSOs, and biopharma companies globally.
In this case study, we highlight the article we wrote for Microscopy Today covering the latest advancements in super-resolution microscopy
Our article on the power of super-resolution microscopy featured in Microscopy Today Read article »
We share our experience creating an interactive infographic showcasing the use of multiomics in spatial biology research for neurodegenerative diseases.
Developing an interactive infographic on spatial multiomics for ALS research Read article »
Life science founders and leaders have a lot to prioritise. While having novel and robust science and products is key,
7 common mistakes when building a content strategy… and how to avoid them! Read article »
In this case study, we summarise the work we did for the market introduction of a new single molecule imaging microscope.
